Victor Margitich Selected Research

enisamium iodide

1/2021	Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity.
1/2018	In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide.
1/2018	Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Margitich Research Topics

Disease

5	Human Influenza (Influenza) 09/2021 - 01/2018
3	COVID-19 09/2021 - 01/2020
2	Coronavirus Infections 09/2021 - 01/2020
1	Non-alcoholic Fatty Liver Disease 02/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	RNA Virus Infections 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

5	enisamiumIBA 09/2021 - 01/2018
5	Antiviral Agents (Antivirals)IBA 09/2021 - 01/2018
3	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 09/2021 - 01/2021
3	enisamium iodideIBA 01/2021 - 01/2018
2	VaccinesIBA 09/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	remdesivirIBA 01/2021 - 01/2020
1	ceric oxide (cerium dioxide)IBA 02/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2021
1	Mefenamic Acid (Pontal)FDA Link 02/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Isonicotinic Acids (Isonicotinic Acid)IBA 01/2020
1	LY 165163 (PAPP)IBA 01/2018

Therapy/Procedure

1	Intravenous Administration 01/2020
1	Therapeutics 01/2018